Concepedia

Christopher Mapperley

CM

4

Publications

722

Citations

4

H-Index

2019

Active since

Affiliations

Queen Mary University of London(Current)

MRC Centre for Regenerative Medicine

University of Edinburgh

University of Cambridge

Wellcome/MRC Cambridge Stem Cell Institute

Christopher Mapperley is an author at Queen Mary University of London specializing in cell signaling, medicine, and cell transplantation.

ORCID

Top concepts

Publications per year

2019–2023

4

Publications

4

Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia

J Paris, Marcos Morgan, Joana Campos et al. · Cell stem cell · 2019 · 542 citations · Full text

The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function

Christopher Mapperley, Louie N. van de Lagemaat, Hannah Lawson et al. · The Journal of Experimental Medicine · 2020 · 141 citations · Full text

, , +18

Mannose metabolism inhibition sensitizes acute myeloid leukaemia cells to therapy by driving ferroptotic cell death

Keith Woodley, Laura S Dillingh, George Giotopoulos et al. · Nature Communications · 2023 · 22 citations · Full text

CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation

Hannah Lawson, Louie N. van de Lagemaat, Melania Barile et al. · Stem Cell Reports · 2021 · 17 citations · Full text

Rows per page

1–4 of 4